Recipharm’s acquisition of the pharma division of Kemwell’s Indian operation has been approved by The Indian Foreign Investment Promotion Board. The closing is expected to occur at the beginning of 2017 and includes the acquisition of Kemwell’s pharmaceutical manufacturing and development operations located in Bengaluru known as Recipharm Pharmaservices Private Ltd.   This past April, Recipharm AB signed two agreements to acquire Kemwell’s pharmaceutical contract development and ma...